Abstract:Immunoinformatic tools can be used to predict schistosome-specific B-cell epitopes with little sequence identity to human proteins and antigens other than the target. This study reports an approach for identifying schistosome peptides mimicking linear B-cell epitopes using in-silico tools and peptide microarray immunoassay validation. Firstly, a comprehensive literature search was conducted to obtain published schistosome-specific peptides and recombinant proteins with the best overall diagnostic performances. For novel peptides, linear B-cell epitopes were predicted from target recombinant proteins using ABCpred, Bcepred and BepiPred 2.0 in-silico tools. Together with the published peptides, predicted peptides with the highest probability of being B-cell epitopes and the lowest sequence identity with proteins from human and other pathogens were selected. Antibodies against the peptides were measured in sera, using peptide microarray immunoassays. Area under the ROC curve was calculated to assess the overall diagnostic performances of the peptides. Peptide AA81008-19-30 had excellent and acceptable diagnostic performances for discriminating S . mansoni and S . haematobium positives from healthy controls, with AUC values of 0.8043 and 0.7326 respectively for IgG. Peptides MS3_10186-123-131, MS3_10385-339-354, SmSPI-177-193, SmSPI-379-388, MS3-10186-40-49 and SmS-197-214 had acceptable diagnostic performances for discriminating S . mansoni positives from healthy controls with AUC values ranging from 0.7098 to 0.7763 for IgG. Peptides SmSPI-359-372, Smp126160-438-452 and MS3 10186-25-41 had acceptable diagnostic performances for discriminating S . mansoni positives from S . mansoni negatives with AUC values of 0.7124, 0.7156 and 0.7115 respectively for IgG. Peptide MS3-10186-40-49 had an acceptable diagnostic performance for discriminating S . mansoni positives from healthy controls, with an AUC value of 0.7413 for IgM. One peptide with a good diagnostic performance and nine peptides with acceptable diagnostic performances were identified using the immunoinformatic approach and peptide microarray validation. There is need for evaluation of the peptides with true negatives and a good standard positive reference. Schistosomiasis, commonly known as bilharzia, is the third most significant tropical disease after malaria and soil-transmitted helminthiases. Like other neglected tropical diseases common in Zimbabwe, schistosomiasis remains mostly undiagnosed or undetected. This is partly due to the fact that reliable identification of parasites requires expertise for specimen preparation, and microscopic examination. Unfortunately, this level of expertise is unavailable in most rural clinics. This limitation is further compounded by the fact that the recommended microscopy-based methods for schistosomiasis diagnosis lack sensitivity, especially in infections of low intensity. To overcome some of the problems associated with microscopy-based methods, highly sensitive serological tests have been utilized. Unfortunately, currently available serological tests have low specificity and show cross-reactivity with other helminthic infections. One way to mitigate cross-reactivity and increase the specificity, is to use immunoinformatic tools and immunoassays to identify schistosomiasis species-specific immunogenic peptides mimicking B-cell epitopes (short amino acid sequences of the antigen that reacts with antibodies). Utilizing immunoinformatic tools coupled with peptide microarray immunoassay validation approach several peptides that can be used to develop diagnostic tools for showing exposure to infection for people living in non-endemic or low-transmission areas were identified in the current study.

Mapping The Antigenic Peptides Of Sm26/2 In Glutathione S-Transferases Of Schistosoma Mansoni

Studies on Antigenic Peptides of Glutathione S-Transferase Sm26/2 of Schistosoma Mansoni

Prediction, Synthesis And Antigenicity Of The Antigenic Peptides Of 26 Kda Glutathione S-Transferase Of Schistosoma Japonicum (Sj26)

Synthesis and Bioactivities of Two Multiple Antigen Peptides As Potential Vaccine Against Schistosoma

Identification of Immunodominant Th1-type T cell Epitopes from <italic>Schistosoma japonicum</italic> 28 kDa Glutathione-S-transferase, a Vaccine Candidate

Studies On Antigenic Peptides Of Paramyosins Of Schistosoma Mansoni And Schistosoma Japonicum

[Prediction of T-cell epitopes from schistosoma japonicum 28 kDa glutathione-S-transferase and identification of their Th1 type T-cell epitopes].

Molecular characterization of a 20.8-kDa Schistosoma mansoni antigen. Sequence similarity to tegumental associated antigens and dynein light chains

Design And Synthesis Of Analogs Of The Schistosoma Mansoni P28 Antigenic Peptide P141

Novel Hepatic Schistosomula Antigens As Promising Targets for Immunodiagnosis and Immunoprotection of Schistosomiasis Japonica.

Evaluation of Recombinant Multi-Epitope Proteins for Diagnosis of Goat Schistosomiasis by Enzyme-Linked Immunosorbent Assay.

Preliminary identification of T cell epitopes on 22.6 kDa antigen of Schistosoma japonicum]

Identification of Schistosoma haematobium and Schistosoma mansoni linear B-cell epitopes with diagnostic potential using in silico immunoinformatic tools and peptide microarray technology

Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice

Immunogenicity of Self-Adjuvanticity Oral Vaccine Candidate Based on Use of Bacillus Subtilis Spore Displaying Schistosoma Japonicum 26 KDa GST Protein

Schistosoma japonicum Tyrosine Hydroxylase is promising targets for immunodiagnosis and immunoprotection of Schistosomiasis japonica

Identification of epitope of 22.6 kDa antigen of Schistosoma japonicum with phage-displayed random peptide library]

Schistosoma japonicum: Efficient and rapid purification of the tetraspanin extracellular loop 2, a potential protective antigen against schistosomiasis in mammalian

A Schistosoma Japonicum Chimeric Protein with A Novel Adjuvant Induced A Polarized Th1 Immune Response and Protection Against Liver Egg Burdens

Immunoinformatic predictions and characterization of Schistosoma mansoni peptides as candidates for immunodiagnostic

Mapping The Binding Between The Tetraspanin Molecule (Sjc23) Of Schistosoma Japonicum And Human Non-Immune Igg